Skip to main content

Terumo Value Stock - Dividend - Research Selection

Terumo Corp.

ISIN: JP3546800008, WKN: 867003

Market price date: 20.01.2022
Market price: 4.236,00 JPY

Terumo Corp. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 21-05-2021
Cash flow
Net operating cash flow 121.485.000.000
Capital Expenditures -62.318.000.000
Free cash flow 59.166.998.528
Balance sheet
Total Equity 856.662.000.000
Liabilities & Shareholders equity 1.351.190.000.000
Income statement
Net income
Eps (diluted) 102,100
Diluted shares outstanding 756.778.000
Net sales/revenue 613.842.000.000

Fundamental ratios calculated on: 20-01-2022

Key figures 20-01-2022
Cash flow
P/C 26,39
P/FC 54,18
Balance sheet
Income statement
Div. Yield0,69%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization30.906.765.312,00 USD
IndicesNIKKEI 225,MSCI World Index
SectorsHealth Care Equipment
Raw Data SourceIFRS in Millionen JPY
Stock Split2019-03-27,2.0000/1.0000; 2019-03-26,2.0000/1.0000; 2014-03-27,2.0000/1.0000; 2014-03-26,2.0000/1.0000

Description of the company

TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, as well as artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. It also manufactures and sells healthcare related products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associated companies.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,